Top compounds associated with response to SLC36A3


Feature Type Standardized
Nominal ANOVA
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.061 0.07
mRNA Crizotinib gCSI pan-cancer AAC -0.1 0.07
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.065 0.07
mRNA TAE684 CTRPv2 pan-cancer AAC -0.063 0.08
mRNA birinapant CTRPv2 pan-cancer AAC -0.068 0.08
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.08
mRNA PL-DI CTRPv2 pan-cancer AAC -0.056 0.08
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.066 0.08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.08
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC 0.096 0.08
Download CSV